Repurposing FDA Approved Asthma Drug to Block Crucial SARS-CoV-2 Protein
In a new study by scientists from the Indian Institute of Science (IISc), repurposing a drug used to treat asthma and allergies has been shown to bind and block a critical protein produced by the virus SARS-CoV-2, reducing viral replication in human immune cells. The US Food and Drug Administration (FDA) approved drug, montelukast, has…

